Oct 6 (Reuters) - Starting breast cancer screening as early as age 25 may help women who carry a genetic mutation linked to a higher risk of cancer live longer, according to a U.S. study.

Researchers, whose findings were reported in the journal Cancer, looked at which breast cancer screenings -- mammogram or magnetic resonance imaging (MRI) -- were effective in women who carry the gene mutations BRCA1 and BRCA2, known to increase the risk of breast and ovarian cancer. They looked at women aged 25, 30, 35 and 40 years old.

The use of CT scans has grown tremendously in the past three decades. The imaging tests, first widely used in the mid-1970s, have become a valuable tool for pinpointing tumors and blood clots, monitoring heart disease, and reducing the need for exploratory surgery. But there is evidence that their use has outpaced need.

The American Medical Association is taking public comment through the end of this week on a proposal to control use of the tests. There are a couple of good reasons for doing that.

Karen Donelan, EdM, ScD was a plenary speaker at the 37th Annual Meeting of the American Academy of Nursing (AAN) on November 12, 2010 in Washington, DC. Dr. Donelan's speech "Healthcare Thoughtleaders’ Perspectives on Nursing in an Era of Reform" presented data from a national survey of healthcare thoughtleaders and stakeholders about the influence and visibility of the nurses and nurse leaders in national health policy debates and emphasized the importance of creating a national database and sampling frame of RNs to enhance research capacity about nursing. Dr. Donelan's speech followed keynote presentations by Pennsylvania Govenor Edward G. Rendell and Donna E. Shalala, PhD, Former US Secretary of Health and Human Services and Chair of the RWJF Initiative on the Future of Nursing at the Institute of Medicine.


Original article from the Mongan Institute for Health Policy